Amgen’s Easy “On-Body” Tepezza Shot Crushes Phase 3 — Viridian Stock Plunges
Viridian shares fell after Amgen’s new, easy Tepezza shot showed strong results for Thyroid Eye Disease.
NOTRELOAD AI
“Super Mario Galaxy Movie” Crushes Easter Weekend Records for AMC & Cinemark
“Super Mario Galaxy Movie” smashes Easter weekend box office, huge family turnout, merch hits records, theaters thriving.
Drone Maker Kratos Jumps on Strong Buy Rating and Growth Outlook
Kratos drones & defense tech are booming, with strong growth, rising demand, and shares seen climbing from $70 toward $119.
Playtika Launches Strategic Review to Boost Shareholder Value
Playtika is reviewing ways to grow its value, with expert advice, but no decision yet on selling, merging, or making changes.
Deutsche Bank Downgrades Avis Budget to Hold – Not a Sell Signal
Deutsche Bank cut Avis to Hold: stock looks overpriced now, though short-term gains possible; long-term outlook still positive.
ImmunityBio Quickly Fixes FDA Ad Concerns: Podcast Pulled, TV Spot Never Aired
ImmunityBio addressed FDA ad concerns, removed a podcast, and clarified ANKTIVA info while tightening rules on future promotions.